• Ensifentrine (Ohtuvayre) for COPD

  • Mar 11 2025
  • Duración: 11 m
  • Podcast

Ensifentrine (Ohtuvayre) for COPD

  • Resumen

  • In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses a new drug for COPD, ensifentrine (Ohtuvayre).

    This is an excerpt from our September 2024 Pharmacy Essential Updates continuing education webinar series.

    The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

    • Article: Watch for Ensifentrine (Ohtuvayre) for COPD
    • Chart: Inhaled Medications for COPD


    Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools.

    If you're a student, good news—students can access a free version of Pharmacist’s Letter.

    Send us a text

    If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

    Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

    You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Ensifentrine (Ohtuvayre) for COPD

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.